ZA200205880B - Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith. - Google Patents

Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith.

Info

Publication number
ZA200205880B
ZA200205880B ZA200205880A ZA200205880A ZA200205880B ZA 200205880 B ZA200205880 B ZA 200205880B ZA 200205880 A ZA200205880 A ZA 200205880A ZA 200205880 A ZA200205880 A ZA 200205880A ZA 200205880 B ZA200205880 B ZA 200205880B
Authority
ZA
South Africa
Prior art keywords
treatment
methods
vascular disease
making same
diabetes
Prior art date
Application number
ZA200205880A
Other languages
English (en)
Inventor
Howard Yoshihisa Ando
Donald Eugene Butler
Gary Jay Dozeman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of ZA200205880B publication Critical patent/ZA200205880B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/305—Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
ZA200205880A 2000-01-25 2002-07-23 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith. ZA200205880B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
ZA200205880B true ZA200205880B (en) 2003-07-23

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205880A ZA200205880B (en) 2000-01-25 2002-07-23 Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith.

Country Status (39)

Country Link
EP (1) EP1259474B1 (enExample)
JP (1) JP4750995B2 (enExample)
KR (1) KR20020073182A (enExample)
CN (1) CN1395555A (enExample)
AP (1) AP2002002587A0 (enExample)
AR (1) AR029436A1 (enExample)
AT (1) ATE431326T1 (enExample)
AU (1) AU2214001A (enExample)
BG (1) BG106851A (enExample)
BR (1) BR0107763A (enExample)
CA (1) CA2397960C (enExample)
CO (1) CO5261537A1 (enExample)
CZ (1) CZ20022474A3 (enExample)
DE (1) DE60138686D1 (enExample)
DK (1) DK1259474T3 (enExample)
DZ (1) DZ3239A1 (enExample)
EA (1) EA004862B1 (enExample)
EE (1) EE200200404A (enExample)
ES (1) ES2324281T3 (enExample)
GE (1) GEP20053428B (enExample)
GT (1) GT200100015A (enExample)
HN (1) HN2001000011A (enExample)
HU (1) HUP0204422A3 (enExample)
IL (1) IL150541A0 (enExample)
IS (1) IS6442A (enExample)
MA (1) MA26867A1 (enExample)
MX (1) MXPA02007223A (enExample)
NO (1) NO20023526L (enExample)
NZ (1) NZ519550A (enExample)
OA (1) OA12166A (enExample)
PA (1) PA8510601A1 (enExample)
PE (1) PE20011064A1 (enExample)
PL (1) PL357076A1 (enExample)
SK (1) SK10622002A3 (enExample)
SV (1) SV2002000290A (enExample)
TN (1) TNSN01013A1 (enExample)
UY (1) UY26550A1 (enExample)
WO (1) WO2001055078A1 (enExample)
ZA (1) ZA200205880B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
WO2004017952A1 (en) * 2002-08-22 2004-03-04 Warner-Lambert Company Llc Method of treating osteoarthritis
CN101163668A (zh) * 2005-04-19 2008-04-16 卫材R&D管理有限公司 双[(2s)-3-[3-(2s)-3-(4-氯-2-氰基苯氧基)-2-氟丙氧基]苯基]-2-异丙氧基丙酸]钙及其中间体
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
CA3059073A1 (en) * 2017-04-18 2018-10-25 Daniela Carmen Oniciu Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
CN113396138A (zh) * 2018-10-18 2021-09-14 燿石治疗公司 吉卡宾、其药学上可接受的盐、其组合物和其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
JP2003520835A (ja) 2003-07-08
UY26550A1 (es) 2001-08-27
CA2397960C (en) 2008-09-09
GT200100015A (es) 2001-10-19
EP1259474A1 (en) 2002-11-27
WO2001055078A1 (en) 2001-08-02
ES2324281T3 (es) 2009-08-04
NO20023526D0 (no) 2002-07-24
DE60138686D1 (de) 2009-06-25
MA26867A1 (fr) 2004-12-20
SK10622002A3 (sk) 2003-07-01
AU2214001A (en) 2001-08-07
EA004862B1 (ru) 2004-08-26
DZ3239A1 (fr) 2001-08-02
GEP20053428B (en) 2005-01-25
MXPA02007223A (es) 2002-11-29
PL357076A1 (en) 2004-07-12
EA200200641A1 (ru) 2002-12-26
KR20020073182A (ko) 2002-09-19
JP4750995B2 (ja) 2011-08-17
EE200200404A (et) 2003-10-15
PE20011064A1 (es) 2001-10-22
CZ20022474A3 (cs) 2003-06-18
EP1259474B1 (en) 2009-05-13
ATE431326T1 (de) 2009-05-15
SV2002000290A (es) 2002-07-16
IS6442A (is) 2002-06-25
IL150541A0 (en) 2003-02-12
CA2397960A1 (en) 2001-08-02
PA8510601A1 (es) 2002-08-26
CO5261537A1 (es) 2003-03-31
HUP0204422A2 (en) 2003-05-28
NZ519550A (en) 2003-11-28
BR0107763A (pt) 2002-11-12
DK1259474T3 (da) 2009-07-20
AP2002002587A0 (en) 2002-09-30
AR029436A1 (es) 2003-06-25
BG106851A (en) 2003-01-31
CN1395555A (zh) 2003-02-05
TNSN01013A1 (fr) 2005-11-10
HUP0204422A3 (en) 2003-08-28
NO20023526L (no) 2002-08-27
HN2001000011A (es) 2001-06-13
OA12166A (en) 2003-11-07

Similar Documents

Publication Publication Date Title
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
ZA200108218B (en) Vascular surgery.
AU2002323258A1 (en) Diagnosis and treatment of vascular disease
MXPA03006753A (es) Tisu absorbente suave.
WO2003057134A3 (en) Specific binding agents of human angiopoietin-2
MXPA03000069A (es) COMPOSICION PARA TRATAMIENTO DE TELAS CON ENJUAGUE AnADIDO, EQUIPO QUE CONTIENE LA MISMA Y METODO DE USO PARA LA MISMA.
MX238203B (es) Tratamiento de semillas con combinaciones de piretrinas, piretroides y tlametoxam.
MXPA03009300A (es) Articulos absorbentes de tipo de calzoncillo y metodos para hacer tales articulos absorbentes.
AU2002367535A1 (en) Diagnosis and treatment of vascular disease
EP1790728A3 (en) Imaging, diagnosis and treatment of disease
MXPA03003836A (es) Tratamiento de espuma de productos de tisu.
ZA200300418B (en) Method of treating cardiovascular disease.
MX233159B (es) Composiciones para tratamientos de telas.
AU2001264042A1 (en) 1,4-diazabicyclo(3.2.2)nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof
ZA200205880B (en) Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith.
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
MXPA02006511A (es) Complejo que comprende factor inhibidor de osteoclastogenesis y polisacarido.
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
WO2001060343A3 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
MXPA03000033A (es) Procedimiento de tratamiento de enfermedades vasculares perifericas, neuropatias perifericas y neuropatias autonomicas.
EG23209A (en) Durable press treatment of fabric.
EP1437141A4 (en) TREATMENTS OF BONE LOSS
MXPA03006162A (es) Derivados de mikanolida, su preparacion y sus usos terapeuticos.
AU2002319591A1 (en) Diagnosis and treatment of vascular disease